China Pacific Insurance floats GDRs on London bourse

Date: 19 Jun 2020

China Pacific Insurance (Group) Co Ltd successfully issued Global Depository Receipts on the London Stock Exchange on Wednesday, making it the first Chinese mainland insurer to be listed in Shanghai, Hong Kong and London simultaneously.

The insurer's GDR started conditional trading on the London bourse on Wednesday, which indicates that GDRs invested during the conditional trading period cannot be converted into underlying A shares within 120 days. The GDR will start official trading on June 22, thereafter the above condition will be removed, said the company in an announcement released on Tuesday.

China Pacific Insurance will offer about 102.87 million GDRs, each of which represents five A shares of the company, said the prospectus. The price of the GDR has been finalized at $17.6 per share. Once the company exercises the overallotment option, which will not exceed 10 percent of the base offering, the total proceeds of the issuance will be around $1.99 billion.

Data from Bloomberg showed that the GDRs issued by China Pacific Insurance are the largest listing by a Chinese company in the European stock market.

The insurance company's chairman, Kong Qingwei, said that the GDR issue will boost economic and trade ties between China and the United Kingdom, and also represents the further opening-up of China's capital market.

The company said in its prospectus that at least 70 percent of the net proceeds will be used for its main insurance businesses, exploring overseas opportunities such as equity investments as well as mergers and acquisitions in developed and emerging markets. The rest will be used to build a venture capital platform, investing in projects related to healthcare, elderly care and other technologies.

The GDR issued by China Pacific Insurance is the second project rolled out under the Shanghai-London stock connect mechanism, which was launched on June 17, 2019. The first project under the stock connect program was the GDR issue of Huatai Securities in June last year.

China Pacific Insurance has introduced Swiss Re Principal Investments Co Asia Pte Ltd as its cornerstone investor. The Swiss reinsurance company has purchased about 28.88 million GDRs, which have a three-year lock-in period.

Liu Xinqi, chief analyst of non-banking financial sector from Guotai Junan Securities, wrote in a note that the introduction of a strategic investor from a developed market will help optimize the corporate governance of China Pacific Insurance. As long-term institutional and strategic investors are the major investors in the GDRs, the prices of the insurer's GDR and shares on the other two bourses will not fluctuate significantly.

The issuance of GDRs will help China Pacific Insurance to build an overseas financing platform to advance its go-global strategy, he said.

The company's results for the first fiscal quarter which ended on March 31, showed that its total sales revenue increased 3.8 percent on a yearly basis to 138.1 billion yuan ($19.5 billion), while net profit surged 53.1 percent to 8.4 billion yuan.

Source: The China Internet Information Center

Click here to view the original article.

The information on this page may have been provided by a contributor to ChinaGoAbroad, and ChinaGoAbroad makes no guarantees about the accuracy of any content. All content shall be used for informational purposes only. Contributors must obtain all necessary licenses and/or ownership rights from the relevant content owner(s) before submitting such content (including texts, pictures, photos and diagrams) to ChinaGoAbroad for publication. ChinaGoAbroad disclaims all liability arising from the publication of any content/information (such as texts, pictures, photos and diagrams that infringe on any copyright) received from contributors. Links may direct to third party sites out of the control of ChinaGoAbroad, and such links shall not be considered an endorsement by ChinaGoAbroad of any information contained on such third party sites. Please refer to our Disclaimer for more details.